Related Experiment Video
Updated: Aug 5, 2026

Measurement of Tactile Allodynia in a Murine Model of Bacterial Prostatitis
Published on: January 16, 2013
Role of bacteria in chronic prostatitis/chronic pelvic pain syndrome
Vi N Hua1, Daniel H Williams, Anthony J Schaeffer
1Department of Urology, Feinberg School of Medicine of Northwestern University, 303 East Chicago Avenue, Tarry 16-703, Chicago, IL 60611, USA.
Abstract:
Throughout the past century, we have refined our understanding of prostatitis, moving from using a primarily clinical definition to considering it as a complex inflammatory condition. The inconsistency in identifying uropathogens in patients with symptoms of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has led to controversy in therapeutic management. There is compelling evidence that the normal prostate has minimal inflammation and no bacteria. Clinicians using the Meares/Stamey criteria identified uropathogens localized to the prostate in only 6% to 8% of CP/CPPS patients. This suggests that bacteria may have a role in less than 10% of men with CP/CPPS. That some patients respond to antimicrobials could suggest that eradication of bacteria reduces symptoms. However, the beneficial effect of antimicrobial drugs may not be due to their antibacterial action, but to their anti-inflammatory action. The normal prostate shows minimal inflammation, but only 50% of CP/CPPS patients exhibit prostatic leukocytosis. Prudence demands that we examine the function of the white blood cells--the cytokines produced. Several basic science advances allowed new avenues of research regarding the detection of molecular evidence of causative uropathogens. New research brings new controversy and unexpected findings, but further refines our understanding of the immune system and the CP/CPPS disease process.
Insights
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a complex inflammatory condition, not primarily bacterial. Research suggests antimicrobial benefits may stem from anti-inflammatory effects rather than antibacterial action in most cases.
Area of Science:
- Urology
- Immunology
- Microbiology
Background:
- Prostatitis understanding evolved from clinical to complex inflammatory condition.
- Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) diagnosis is debated due to inconsistent uropathogen identification.
- Normal prostate has minimal inflammation and no bacteria.
Purpose of the Study:
- To review the evolving understanding of prostatitis, particularly CP/CPPS.
- To investigate the role of bacteria and inflammation in CP/CPPS.
- To explore new research avenues for detecting causative agents and understanding immune responses.
Main Methods:
- Review of clinical definitions and diagnostic criteria (Meares/Stamey).
- Analysis of uropathogen detection rates in CP/CPPS patients.
- Examination of inflammatory markers (leukocytosis, cytokines) in the prostate.
- Consideration of basic science advances in molecular detection.
Main Results:
- Uropathogens identified in only 6-8% of CP/CPPS patients using Meares/Stamey criteria.
- Bacteria likely play a role in less than 10% of CP/CPPS cases.
- Antimicrobial efficacy may be linked to anti-inflammatory rather than antibacterial action.
- Prostatic leukocytosis present in only 50% of CP/CPPS patients.
Conclusions:
- CP/CPPS is a complex inflammatory condition where bacterial infection is not the primary cause for most patients.
- The anti-inflammatory effects of antimicrobials may be more significant than their antibacterial properties.
- Further research into immune system function and molecular detection is crucial for understanding CP/CPPS.
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis I: Introduction
Bacterial Phylum Spirochaetes
Microbiota of the Urogenital Tract

